AtriCure Announces the First Patient Enrolled in International Afib Study
Go back to AtriCure Announces the First Patient Enrolled in International Afib Study| AtriCure, Inc. (NASDAQ: ATRC) | Delayed: 48.92 +0.57 (1.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.35 | 52 Week High | $23.24 | |||
| Open | $48.43 | 52 Week Low | $13.44 | |||
| Day High | $49.25 | P/E | N/A | |||
| Day Low | $47.54 | EPS | $-0.45 | |||
| Volume | 718,137 | |||||
